Insmed
INSM
119 hedge funds and large institutions have $1.12B invested in Insmed in 2015 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 20 reducing their positions, and 9 closing their positions.
256% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 9
135% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 20
70% more capital invested
Capital invested by funds: $656M → $1.12B (+$462M)
24% more funds holding
Funds holding: 96 → 119 (+23)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less call options, than puts
Call options by funds: $2.85M | Put options by funds: $3.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$140M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$17.2M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$10.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$8.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.9M |
| 2 |
DM
Deerfield Management
New York
|
-$10.8M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
-$4.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.5M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$2.44M |
INSM Hedge Fund Activity: Q1 2015 in Review
119 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2015, worth a combined $1.12B — up 70% from $656M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new INSM positions and 9 closed out — a net gain of 23 holders — while 47 added to existing stakes and 20 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $140M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $43.9M sold.
- 119 institutional investors held Insmed (INSM) as of Q1 2015, up from 96 in Q4 2014.
- Funds reported $1.12B of Insmed stock for Q1 2015, up 70% quarter-over-quarter.
- 32 funds opened new Insmed positions in Q1 2015 and 9 closed out, a net change of +23 holders.
- The largest Insmed buyer in Q1 2015 was T. Rowe Price Associates, an estimated $140M added.
- The largest Insmed seller in Q1 2015 was Point72 Asset Management, an estimated $43.9M sold.
Based on aggregated 13F filings for Q1 2015.